BlackRock Health Sciences Opportunities Portfolio

BlackRock Health Sciences Opportunities Portfolio is an actively managed mutual fund that focuses on the health sciences sector. Its primary objective is long-term capital growth by investing at least 80% of its assets in equity securities—mainly common stocks—of companies involved in health sciences and related industries. These industries span biotechnology, pharmaceuticals, health care equipment and supplies, and health care providers and services. The fund often maintains a concentrated portfolio, with a significant portion of its assets in its top ten holdings, which typically include major industry leaders such as Eli Lilly, UnitedHealth Group, AbbVie, and Boston Scientific. While predominantly invested in U.S. companies, the portfolio may also include select international firms, offering additional sector diversification. It is managed by BlackRock’s team, which utilizes both fundamental research and a disciplined investment process to identify companies poised for above-average growth or trading below their intrinsic value. By focusing on innovation and long-term industry trends, the fund plays a pivotal role in providing sector-specific exposure for investors seeking participation in the evolving health care landscape.